Tenax Therapeutics Inc. (NASDAQ:TENX) went up by 0.30% during the previous trading session, and it is maintaining the win ahead of Thursday’s trading session. The share price of the Biotechnology giant went up by $0.90 to trade ended Thursday trading at $0.90. This is up from the $0.9 price recorded on Wednesday’s trading session. Thanks to this latest performance, TENX is closer to the higher price 52-week target of $4.45 and further from the lowest price target of $4.00. Its performance from the start of the year has also been negative, with TENX down by -35.98% year-to-date.
Tenax Therapeutics Inc. (TENX) started the day trading at $0.9399 and recorded an intraday high of $0.98. It also recorded an intraday low of $0.902 during Thursday’s trading session. Tenax Therapeutics Inc. is a very active stock that recorded a trading volume that is less than -496.36% of the average daily trading volume on Thursday. The stock’s trading volume on Thursday was 224696, which is less than -496.36 of the total average daily trading volume of 1.34 million.
Tenax Therapeutics Inc. (NASDAQ:TENX) 2020 Performance Impressive
The increase in TENX’s stock price on Thursday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of TENX currently stands at $2.68, which is higher than the current trading price of the stock by 66.42%. However, TENX’s current trading price is -260.0% lower than the 52-week low price of $0.25. In terms of trading volume, Tenax Therapeutics Inc. currently experienced healthy participation during the last trading session. 224696 shares of Tenax Therapeutics Inc. were traded on the stock exchange on Thursday, which is less than -496.36% of the 1.34 million average trading volume of the stock.
The performance of the stock has been positive over the past year. TENX’s performance over the past one year has seen it plunge by -33.38%, while the stock has gone down by -36.20% in the last six months. The quarterly performance of TENX currently stands at 65.63%, and it is down by -39.82% in the last month. The only negative figure was from the weekly performance, which currently reads -2.53%. At the time of writing TENX’s report, the company has a total market cap of $7.99M, making it one of the largest publicly-traded companies in the world.Tenax Therapeutics Inc. also has over 9 employees all over the world.
TENX Insider Activities
For Tenax Therapeutics Inc., insiders hold 20.50% of all company shares. The insider transactions over the past six months are up by 16.10%. During that period, insiders bought 5,000 shares in 1 transactions. In that same period, insiders sold 0 of their shares in 0 transactions. After these transactions, insiders at Tenax Therapeutics Inc. now hold 36.14k shares, which is over 21.77% of the total company stocks. Institutional investors currently hold a large chunk of the TENX shares, as they control 0.39% of the company’s total stock.
TENX Fundamental Analysis
For Tenax Therapeutics Inc., the stock’s diluted earnings per share (EPS) stands at -1.40. In the coming year, analysts expect the EPS to be -1.01. The stock’s EPS growth this year is 85.00%, 33.00% in the previous five years. In terms of revenue, Tenax Therapeutics Inc.’s quarterly sales (YOY) is shrinking at -0.21, which is lower than the average annual revenue of 33.00% over the past half a decade.
TENX Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of TENX currently stands at -20.01%, while the SMA50 is -10.66%. The biggest one is the SMA200, which is currently reading -16.95% ahead of Thursday’s trading session. The Relative Strength Index of this stock is 39.84.
